Implantable hearing solutions provider Cochlear has secured approval from the US Food and Drug Administration (FDA) for its new Kanso hearing loss solution.
The company has developed new Kanso solution for the treatment of severe to profound hearing loss.
Kanso is a small and off-the-ear hearing device that will be worn worn on the user’s head without the support of anything behind the ear.
Kanso sound processor features a single on/off button with no cables, dual microphones, as well as an advanced hearing technology.
The new hearing loss solution includes SmartSound iQ with Scan, which enables the sound processor to automatically adjust to different listening environments.
According to the company, the Kanso sound processor will be available in eight colors,, helping the device to fuse with a wide range of hair colors.
Cochlear produces cochlear implants, bone conduction and acoustic implants to treat a range of moderate to profound types of hearing loss.
Cochlear North America president Tony Manna said: “Our recipients are at the heart of everything we do at Cochlear, and delivering Kanso to the market is in direct response to us listening to our customers.
“Through customer feedback, we identified the need for a new solution that provides the advanced technology and hearing performance of our latest cochlear implant sound processor, which is worn behind the ear, in an easy and discreet design with access to wireless and water accessories, all without losing the high-quality hearing experience our customers expect from our products.”
Image: Cochlear’s new Kanso hearing loss solution. Photo: courtesy of PRNewsFoto / Cochlear.